What is the current market price of ritexitinib? What is the price difference between different specifications?

Ritlecitinib is a new type of JAK3/TEC kinase inhibitor, mainly used to treat moderate to severe alopecia areata, especially for adults and adolescent patients with refractory alopecia. By inhibiting JAK3 kinase, it intervenes in the abnormal pathways leading to immune response, thereby effectively improving hair loss symptoms caused by immune system abnormalities. Ritexitinib is approved to treat alopecia areata in patients over the age of 12 and has shown significant efficacy in clinical trials, helping most patients restore hair growth.

Although ritexitinib has been approved in many countries, in China, although the original version of the drug has been marketed, it has not yet been included in medical insurance. According to the market situation, the current common specification in the domestic market is 50mg*30 capsules, with each box selling for about more than 3,000 yuan. Taking into account the import costs, logistics and other factors of the drug, the domestic price of ritexitinib may be relatively high.

In overseas markets, the price of ritexitinib is more expensive, especially in the European market, where the price of each box of the European version of the original drug may exceed more than 10,000 yuan. Prices may fluctuate due to exchange rate fluctuations. Compared with original drugs, there are also some generic drugs on the market in overseas markets. For example, the generic version produced in Laos has similar specifications to the original drug, and the price per box is about more than 700 yuan. The main advantage of generic drugs is that they are relatively cheap, making them a viable alternative for patients with heavy financial burdens.

Generally speaking, the price of ritexitinib is affected by many factors, including the country where the drug is produced, exchange rate fluctuations, and market supply and demand. At present, because drugs are not yet fully covered by medical insurance, patients need to weigh the price of the drug and their personal financial situation when choosing to purchase it. In addition, due to increasing global demand for the drug, the market price of ritexitinib may gradually adjust over time.

Reference materials:https://www.litfulo.com/